Screening for Hypoglycemia in an Institutionalized Elderly Diabetic Population.
HAGED
1 other identifier
observational
29
1 country
1
Brief Summary
Diabetes is a major public health problem that has been growing steadily in recent years. Its prevalence is very high in the elderly, in whom there is an increased risk of hypoglycemia. Hypoglycaemia in elderly diabetics has serious consequences:
- increased mortality,
- increased cardiovascular morbidity,
- increased risk of falling,
- impairment of quality of life.
- Hypoglycaemia is also a risk factor for dementia in type 2 diabetes. The frequency of asymptomatic and atypical hypoglycemia has been shown to be greater in the elderly, but the exact prevalence of hypoglycemia in the elderly remains unknown. Elderly diabetic patients in institutions are particularly fragile and have more frequent cognitive problems than non-diabetic subjects. A study conducted in this population of patients showed that a third of them had HbA1C \<6.5%, which suggests a higher frequency of hypoglycemia though the figures were not available. We therefore decided to conduct a study to assess the frequency of hypoglycemia in order to better understand the contributing factors and to improve the management of this fragile population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2018
CompletedFirst Posted
Study publicly available on registry
September 4, 2018
CompletedStudy Start
First participant enrolled
January 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 11, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 11, 2019
CompletedFebruary 4, 2026
February 1, 2026
5 months
August 31, 2018
February 2, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Number of hypoglycemic events (<70 mg/dl) demonstrated by continuous interstitial glucose monitoring over the study period.
Day 14
Number of hypoglycemic events (<70 mg/dl) detected by capillary blood glucose measurement or clinical signs suggestive of hypoglycemia.
Day 14
Interventions
Installing and removing the sensor
Scan of the sensor, using the Freestyle Pro free version reader, at installation then before removal after 14 days.
Eligibility Criteria
Patient institutionalized in EHPAD
You may qualify if:
- written consent
- diabetic patient receiving treatment which could result in hypoglycemia: insulin and/or sulfonamide and/or glinides
- institutionalized patient in an EHPAD
- patient over 60 years of age
You may not qualify if:
- \- person not affiliated to a national health insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Dijon Bourogne
Dijon, 21000, France
Related Publications (1)
Bouillet B, Tscherter P, Vaillard L, Nonciaux C, Hourdain P, Ravier A, Rouland A, Petit JM, Verges B, Quilot E. Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes. Age Ageing. 2021 Nov 10;50(6):2088-2093. doi: 10.1093/ageing/afab128.
PMID: 34324624RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2018
First Posted
September 4, 2018
Study Start
January 8, 2019
Primary Completion
June 11, 2019
Study Completion
June 11, 2019
Last Updated
February 4, 2026
Record last verified: 2026-02